Lipoproteins and Lipid Transport

Cholesterol Synthesis
-
cholesterol only comes from animal products
-
humans can survive on cholesterol-free diet (ex. vegan) because our body can synthesize cholesterol using acetyl-CoA
-
in the cytoplasm and ER of all cells with a nucleus​
-
major tissues/organs: liver, intestine
-
mevalonate and squalene are important intermediates
-
-
LDL receptor mediates cholesterol uptake in cells
CHL Synthesis - Regulation
-
cholesterol biosynthetic pathway (HMG CoA synthase and HMG CoA reductase) is regulated at the transcriptional level (HMG: 3-hydroxy-3-methylglutaryl-coenzyme A)
-
cholesterol is an end product feedback inhibitor (negative feedback) when [CHL] is high​​
-
​​
-
-
​
-
HMG CoA reductase is the primary target
-
statins (ex. lipitor) inhibit (competetive)​
-
CHL --> faster degredation of HMG CoA reductase
-
phosphorylation --> less active enzyme
-

-
3 Acetyl CoA --------> HMG CoA --> mevalonate



Apolipoproteins (Apo)
-
protein component of lipoproteins
-
different apolipoproteins give lipoproteins their identity
-
letters A to E used
-
some exceptions ex. ApoB-48​
-
FUNCTIONS
-
stabilize lipoproteins
-
serve as markers to be recognized
-
give lipoproteins their "identity"​
-
-
affect enzyme activity

Major Lipases
LIPOPROTEIN LIPASE
-
TAG --> 3 FFA + glycerol
-
works on TAGs from chylomicrons and VLDL (endogenous)
-
in capillary wall near tissue
PANCREATIC LIPASE
-
TAG --> 2 FFA + MAG
-
works on TAGs you just ate
-
pancreas --> lumen of GI
Transport of Lipids
Chylomicrons deliver TAG from GI to adipose and muscle
-
ApoB-48​
-
TAGs don't enter tissues​​​
-
TAGs are hydrolyzed first to glycerol and FFAs by an enzyme called lipoprotein lipase (LPL)
-
LPL is bound to inside of capillary walls​
-
is a glycoprotein
-
gene present in muscle, adipose and heart
-
activated by apoC II
-
LPL in adipose tissue is insulin sensitive
-


Chylomicrons deliver TAG from GI to adipose and muscle
-
glycerol stays in the blood
-
FFAs enter cells
-
inside cells they are reincorporated into TAGs
-
they new glycerol for TAG synthesis comes from glucose in the cell​
-
-
in adipose tissue, TAGs can also be made from FFA that the adipose tissues synthesizes



-
Dietary TAGs in chylomicrons are not the only source of TAGs
-
after a meal (high in CHO therefore excess energy) and during all 24 hours of the day, the liver synthesizes FA and forms TAGs from glucose
-
Liver does not store TAG but exports as VLDL
-
released to systemic blood to peripheral tissues​
-
if TAG accumulates in blood, it leads to fatty liver disease
-
therefore, adipose tissue receives TAG from both chylo and VLDL
-
-
after chylomicrons and VLDL deliver TAG to tissues, there are remnants with much lower TAG content
-
chylo remnants go to liver​
-
VLDL remnants are used to make
-
IDL​
-
LDL
-
-



Lipoproteins
Chylomicrons​​
-
transports dietary TGs from the GI to the liver, adipose tissue and muscle
-
carries dietary TGs > CE
Chylomicron remnants
-
chylomicrons after most of the TG is removed within the capillary beds of muscle and adipose tissue by the action of LPL
-
carries dietary CHL

VLDL
-
transports mostly TGs, some CHL, from liver to periphery
-
carries endogenous TGs
IDL
-
transient; derived from VLDL in the capillaries of adipose tissue and muscle after the extraction of TGs by LPL in the capillary beds
LDL
-
derived from VLDL
-
carries endogenous CHL
HDL
-
collect free CHL from other lipoproteins and cells and sends it to liver for "reverse transport" of CHL from cells to liver
-
carries CHL
-
net effect: collect CHL from peripheral cells and other lipoproteins and send back to the liver
-
in liver, CHL is used to synthesize bile acids
-
fecal disposal of bile acids is the main route for CHL to leave our bodies


LDL METABOLISM
-
LDL delivers CHL to tissues
-
tissues need LDL receptors to uptake LDL
-
LDL receptors:
-
transmembrane glycoprotein​
-
interacts with apoB-100
-
internalized by endocytosis
-
once inside cell...
-
LDL receptors release LDL and go back to the surface of cell
-
LDL is processed in lysosome
-
AAs
-
FFA
-
free CHL
-
decreases HMG CoA reductase abundance​
-
activates ACAT --> increases CE synthesis
-
decreases LDL receptor --> decreases LDL take in
-
-
LDL + apo(a) = lipoprotein A
-
Apo (a)
-
LDL-apoB-100 linked to apo(a) via disulfide bond​
-
structure homology between apo)a) and plasminogen
-
plasminogen binds to fibrin and dissolves blood clot
-
because apo(a) has similar structure, it competes with plasminogen and competes with fibrinogen
-
risk factor for CVD
-
-
apo(a) is linked to apoB-100 on LDL
-
apo(a) brings CHL to site of injury
-

Dietary fat and CVD
positive correlation
-
total fat
-
saturated FAs
-
CHL
-
trans fat
negative correlation
-
MUFA
-
PUFA
​
Stearic acid (18:0)
